Orbimed Advisors LLC Repare Therapeutics Inc. Transaction History
Orbimed Advisors LLC
- $3.21 Billion
- Q1 2025
A detailed history of Orbimed Advisors LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 3,322,488 shares of RPTX stock, worth $4.98 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,322,488
Previous 3,322,488
-0.0%
Holding current value
$4.98 Million
Previous $4.35 Million
24.43%
% of portfolio
0.1%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding RPTX
# of Institutions
54Shares Held
32.5MCall Options Held
50KPut Options Held
900-
Bvf Inc San Francisco, CA10.3MShares$15.5 Million0.45% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.44MShares$5.17 Million1.76% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$4.45 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$3.97 Million5.46% of portfolio
-
Redmile Group, LLC San Francisco, CA1.88MShares$2.83 Million0.2% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $62.9M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...